Publication | Open Access
<p>Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system</p>
13
Citations
23
References
2019
Year
In summary, CMAB008 might have the potential to be an effective drug compared with infliximab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1